Xiaoying Chen: Rethinking Thrombectomy in Large-Core Stroke – Insights from LASTE Analysis
Xiaoying Chen, Senior Research Fellow at The George Institute for Global Health, shared on LinkedIn about a recent article by Bertrand Lapergue et al, published in Stroke, adding:
”One of the hardest questions in acute stroke is how far we can safely extend reperfusion treatment in patients with very large established infarcts.
This secondary analysis from LASTE suggests that even patients with ASPECTS 0–2 should not be treated as a uniformly futile group, with signals for better outcomes and lower mortality after thrombectomy.
From my perspective, this is exactly where modern stroke trials need to go next: not broad over-simplifications of ‘large core’ stroke, but smarter subgroup learning that can identify where benefit persists, where bleeding risk rises, and how more precise treatment decisions can be made in real-world practice.”
Title: Endovascular Thrombectomy in Patients With Largest Baseline Infarcts (ASPECTS 0–2): An Ancillary Analysis of the LASTE Trial
Authors: Bertrand Lapergue, Caroline Arquizan, J.F. Albucher, Christophe Cognard, Hilde Henon, Nasreddine Nouri, Benjamin Gory, Sebastien Richard, Gauthier Marnat, Igor Sibon, Federico Di Maria, Mariam Annan, Grégoire Boulouis, Pere Cardona, Julien Labreuche, Vincent Costalat, Tudor Jovin
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal